Tounjian Advisory Partners LLC acquired a new stake in shares of Kimberly-Clark Co. (NYSE:KMB - Free Report) during the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm acquired 8,286 shares of the company's stock, valued at approximately $1,179,000.
A number of other hedge funds also recently made changes to their positions in the company. Vanguard Group Inc. raised its stake in shares of Kimberly-Clark by 15.1% during the fourth quarter. Vanguard Group Inc. now owns 35,142,545 shares of the company's stock valued at $4,605,079,000 after purchasing an additional 4,603,787 shares during the period. Charles Schwab Investment Management Inc. raised its stake in shares of Kimberly-Clark by 5.3% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 10,589,967 shares of the company's stock valued at $1,387,709,000 after purchasing an additional 529,223 shares during the period. Geode Capital Management LLC raised its stake in shares of Kimberly-Clark by 10.4% during the fourth quarter. Geode Capital Management LLC now owns 8,473,459 shares of the company's stock valued at $1,113,444,000 after purchasing an additional 797,953 shares during the period. Price T Rowe Associates Inc. MD raised its stake in shares of Kimberly-Clark by 5.9% during the fourth quarter. Price T Rowe Associates Inc. MD now owns 7,529,108 shares of the company's stock valued at $986,616,000 after purchasing an additional 417,118 shares during the period. Finally, Invesco Ltd. raised its stake in shares of Kimberly-Clark by 21.9% during the fourth quarter. Invesco Ltd. now owns 5,653,751 shares of the company's stock valued at $740,868,000 after purchasing an additional 1,015,141 shares during the period. Hedge funds and other institutional investors own 76.29% of the company's stock.
Insider Activity at Kimberly-Clark
In related news, insider Katy Chen sold 740 shares of the firm's stock in a transaction that occurred on Friday, May 2nd. The stock was sold at an average price of $129.70, for a total value of $95,978.00. Following the sale, the insider now directly owns 3,997 shares in the company, valued at $518,410.90. This trade represents a 15.62% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. 0.64% of the stock is owned by insiders.
Kimberly-Clark Stock Performance
Kimberly-Clark stock traded down $0.19 during mid-day trading on Wednesday, reaching $132.85. The company's stock had a trading volume of 1,679,968 shares, compared to its average volume of 2,181,085. Kimberly-Clark Co. has a twelve month low of $124.10 and a twelve month high of $150.45. The firm has a market cap of $44.08 billion, a price-to-earnings ratio of 17.60, a PEG ratio of 4.46 and a beta of 0.38. The company has a current ratio of 0.80, a quick ratio of 0.54 and a debt-to-equity ratio of 7.05. The business has a 50 day moving average price of $136.76 and a 200-day moving average price of $135.37.
Kimberly-Clark (NYSE:KMB - Get Free Report) last issued its quarterly earnings data on Tuesday, April 22nd. The company reported $1.93 earnings per share for the quarter, beating the consensus estimate of $1.89 by $0.04. Kimberly-Clark had a net margin of 12.69% and a return on equity of 201.43%. The firm had revenue of $4.84 billion for the quarter, compared to the consensus estimate of $4.90 billion. During the same period last year, the firm posted $2.01 EPS. Sell-side analysts predict that Kimberly-Clark Co. will post 7.5 EPS for the current fiscal year.
Kimberly-Clark Dividend Announcement
The firm also recently announced a quarterly dividend, which will be paid on Wednesday, July 2nd. Investors of record on Friday, June 6th will be given a $1.26 dividend. This represents a $5.04 annualized dividend and a yield of 3.79%. The ex-dividend date is Friday, June 6th. Kimberly-Clark's dividend payout ratio is currently 68.66%.
Wall Street Analysts Forecast Growth
A number of analysts have recently issued reports on KMB shares. UBS Group lifted their price objective on shares of Kimberly-Clark from $134.00 to $146.00 and gave the company a "neutral" rating in a research note on Thursday, April 17th. Piper Sandler dropped their price target on shares of Kimberly-Clark from $158.00 to $156.00 and set an "overweight" rating for the company in a research note on Wednesday, April 23rd. JPMorgan Chase & Co. lifted their price target on shares of Kimberly-Clark from $124.00 to $131.00 and gave the stock an "underweight" rating in a research note on Friday, April 11th. Barclays dropped their price target on shares of Kimberly-Clark from $139.00 to $135.00 and set an "equal weight" rating for the company in a research note on Thursday, April 24th. Finally, Royal Bank of Canada dropped their price target on shares of Kimberly-Clark from $165.00 to $162.00 and set an "outperform" rating for the company in a research note on Wednesday, April 23rd. Two analysts have rated the stock with a sell rating, eight have issued a hold rating and four have issued a buy rating to the stock. Based on data from MarketBeat.com, the company has an average rating of "Hold" and an average target price of $145.08.
Check Out Our Latest Stock Analysis on Kimberly-Clark
About Kimberly-Clark
(
Free Report)
Kimberly-Clark Corporation, together with its subsidiaries, manufactures and markets personal care and consumer tissue products in the United States. It operates through three segments: Personal Care, Consumer Tissue, and K-C Professional. The company's Personal Care segment offers disposable diapers, training and youth pants, swimpants, baby wipes, feminine and incontinence care products, reusable underwear, and other related products under the Huggies, Pull-Ups, Little Swimmers, GoodNites, DryNites, Sweety, Kotex, U by Kotex, Intimus, Thinx, Poise, Depend, Plenitud, Softex, and other brand names.
See Also

Before you consider Kimberly-Clark, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Kimberly-Clark wasn't on the list.
While Kimberly-Clark currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report